Current Events

Nissan's (7201.T) Infiniti luxury brand will recall roughly 60,000 vehicles globally, a spokesman for the brand said on Thursday, as the steering system key to the Q50 sedan's autonomous driving capabilities could malfunction.

The recall will affect cars in all markets where the Q50 is sold, including China and North America, spokesman Stefan Weinmann said in a written statement.

Read more . . .

With or without eyes in the back of their heads, drivers keep hitting things.

Despite the growing prevalence of back-up cameras, federal data shows that this technology hasn't significantly cut down on cars backing into people and causing them harm. That research on so-called "back-over incidents" comes as the National Highway Traffic Safety Administration moves to make back-up cameras standard and presses automakers to add a bevy of new technologies -- from automatic braking to lane collision warnings -- to even entry-level cars to reduce accidents on the road.

Read more . . .

The complaint was filed this week in  Georgia’s Northern District Court.

Plaintiffs in the case, Gabrial Nassar Cure and Dr.
Read more . . .

For two years, a group of families in Newtown, Conn., quietly laid the groundwork for a legal case against the maker and sellers of the assault rifle that on Dec. 14, 2012, claimed 26 lives — and shattered their own — in less than five minutes.

The shooting at Sandy Hook Elementary School was carried out with an AR-15, a military-style assault rifle that has surfaced in recent mass shootings, like Aurora, Colo., and San Bernardino, Calif.
Read more . . .

Congress can fight antibiotic resistance by funding programs to curb unnecessary prescriptions, speeding up the drug development process and improving testing to determine whether a patient has a virus or a bacterial infection, federal government health experts said Tuesday.

They spoke at a hearing by the House Energy and Commerce Committee's Oversight and Investigations Subcommittee on the U.S. public health response to antibiotic resistance.

In fiscal 2016, Congress allocated more than $830 million to address antibiotic resistance and the White House has requested $1.
Read more . . .

The FDA is strengthening a warning on the labels of two diabetes drugs to reflect risk of acute kidney injuries.

New labels for the two sodium-glucose transport 2 (SGLT-2) drugs -- canagliflozin (Invokana) and dapagliflozin (Farxiga) -- will have more information about acute kidney injuries and add recommendations about how to minimize risk, said the FDA on its website Tuesday.

The agency says that the strengthened warning comes after they have received reports of 101 confirmable cases of acute kidney injury from March of 2013 to October of 2015. Some of those cases required hospitalization and dialysis. "This number includes only reports submitted to FDA, so there are likely additional cases about which we are unaware," according to the posted statement.
Read more . . .

DETROIT (AP) - BMW is recalling 622,000 SUVs worldwide because the child seat anchors may become damaged and won't hold the seat properly.

The recall covers certain X3 SUVs from the 2011 to 2017 model years, as well as some X4s from 2015 through 2017. It includes nearly 189,000 vehicles in the U.S.

BMW says in documents posted Tuesday by the U.
Read more . . .

Three of the most contentious questions in American culture and politics — gay rights, gun control and terrorism — collided in a horrific way in an Orlando nightclub early Sunday.

It is not entirely clear what inspired Omar Mateen to Read more . . .

It's the most dramatic courtroom moment: The jurors announce their verdict, and the judge tells them they're free to go.

But the Supreme Court ruled Thursday that judges can call those jurors back, tell them to deliberate all over again, and bring a new ending to the legal drama if there's been a mistake.

The case stems from one man running a red light in Montana. Rocky Dietz was driving to the gas station when a car driven by another man, Hillary Bouldin, ran a red light and crashed into his car.

Dietz sued Bouldin for the cost of physical therapy to treat a back injury and other medical expenses.
Read more . . .

WASHINGTON (Reuters) - Pharmaceutical companies Genentech and OSI Pharmaceuticals LLC will pay $67 million to resolve allegations they made misleading statements about the effectiveness of lung cancer drug Tarceva, the U.S. Justice Department said on Monday.

The claims alleged that between 2006 and 2011, the companies misrepresented the effectiveness of Tarceva to physicians and other healthcare providers to treat certain patients with non-small cell lung cancer, the department said in a statement.

Read more . . .

Higher than recommended doses of diarrhea drug loperamide (Imodium) can cause serious and even fatal cardiac arrhythmias, the FDA warned.

Although some of the 48 cases of QT interval prolongation, torsades de pointes, cardiac arrest, syncope, and other serious cardiac events reported to the agency have been unintentional misuse of more than the maximum daily dose for adults (8 mg in over-the-counter products; 16 mg in prescription use), most have been intentional abuse.

"The majority of reported serious heart problems occurred in individuals who were intentionally misusing and abusing high doses of loperamide in attempts to self-treat opioid withdrawal symptoms or to achieve a feeling of euphoria," the agency noted in a Drug Safety Communication.

Loperamide is a mu-opioid agonist that acts primarily in the gut but, in high doses, has psychoactive effects. It has recently been recognized as a drug of abuse and is recommended in internet chat forums for treating symptoms of opioid withdrawal.
Read more . . .